- Home
- TENX vs TRT Comparison
TENX vs TRT Comparison
Compare TENX & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- TRT
- Stock Information
- Founded
- TENX 1967
- TRT 1958
- Country
- TENX United States
- TRT United States
- Employees
- TENX 6
- TRT N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- TRT Industrial Machinery/Components
- Sector
- TENX Health Care
- TRT Technology
- Exchange
- TENX Nasdaq
- TRT Nasdaq
- Market Cap
- TENX 21.6M
- TRT 22.2M
- IPO Year
- TENX N/A
- TRT N/A
- Fundamental
- Price
- TENX $5.53
- TRT $4.93
- Analyst Decision
- TENX Strong Buy
- TRT
- Analyst Count
- TENX 3
- TRT 0
- Target Price
- TENX $16.00
- TRT N/A
- AVG Volume (30 Days)
- TENX 18.4K
- TRT 10.3K
- Earning Date
- TENX 05-13-2025
- TRT 05-12-2025
- Dividend Yield
- TENX N/A
- TRT N/A
- EPS Growth
- TENX N/A
- TRT N/A
- EPS
- TENX N/A
- TRT 0.13
- Revenue
- TENX N/A
- TRT $38,562,000.00
- Revenue This Year
- TENX N/A
- TRT N/A
- Revenue Next Year
- TENX N/A
- TRT N/A
- P/E Ratio
- TENX N/A
- TRT $37.51
- Revenue Growth
- TENX N/A
- TRT N/A
- 52 Week Low
- TENX $2.77
- TRT $4.90
- 52 Week High
- TENX $7.89
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- TENX 42.57
- TRT 35.10
- Support Level
- TENX $4.63
- TRT $4.90
- Resistance Level
- TENX $5.75
- TRT $5.15
- Average True Range (ATR)
- TENX 0.42
- TRT 0.30
- MACD
- TENX -0.04
- TRT -0.06
- Stochastic Oscillator
- TENX 47.70
- TRT 17.39
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.